logo
Select company
Select metric
Ticker Information

Ticker

KTTA

Company Name

PASITHEA THERAPEUTICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PASITHEA THERAPEUTICS CORP - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KTTA - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -12.81M0%$ 0
3/31/2025$ -12.96M0%$ 0
12/31/2024$ -13.26M0%$ 0
9/30/2024$ -15.13M0%$ 0
6/30/2024$ -15.74M0%$ 0
3/31/2024$ -15.64M0%$ 0
12/31/2023$ -15.31M0%$ 0
9/30/2023$ -15.46M-6423.18%$ 240.71K
6/30/2023$ -16.58M-3610%$ 459.32K
3/31/2023$ -15.63M-3305.13%$ 472.9K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for PASITHEA THERAPEUTICS CORP is calculated as follows: EBITDA [ $ -40.98K ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

KTTA - EBITDA Margin, Last 5 years

-14417.97%

Minimum

Dec 31, 2021

-2842.34%

Maximum

Dec 31, 2022

-7114.76%

Average

-5016.59%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%